为解决肝细胞癌（HCC）预后差、缺乏有效生物标志物的问题，研究人员开展了 RECQL4 在 HCC 中作用的研究，发现其可预测预后、影响药物敏感性，对 HCC 治疗意义重大。 肝细胞癌（Hepatocellular carcinoma，HCC），这个隐匿在人体肝脏内的 “健康杀手”，一直以来都是全球癌症领域的一大难题。它不仅是全球第六大常见癌症，更是癌症相关死亡的第三大主因。多数 HCC ...

The leading Advanced Merkel Cell Carcinoma Companies such as Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, ...

"Adherence to the Mediterranean diet has been linked with reduced central adiposity, lower BMI [body mass index], and less ...

为解决肝细胞癌（HCC）患者等待肝移植期间肿瘤进展问题，相关研究人员开展 Histotripsy 作为桥接治疗的研究，发现其可使肿瘤完全坏死，为 HCC 治疗提供新选择。

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

Ins("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid Bioscience, a South ...

A Whakatāne man with terminal cancer says he has outlived his life expectancy after joining a trial for cancer drugs that ...

Embolization has made remarkable advances in recent years, becoming a widely adopted treatment option. The FDA approved the ...

Clinical data from Indaptus’ ongoing Phase 1 trial evaluating Decoy20 in advanced solid tumors.

2月22日（北京时间），中国科学院院士、东南大学附属中大医院滕皋军教授联合国内外专家学者，在医学领域国际顶级期刊《Lancet Gastroenterology & ...

Intrahepatic cholangiocarcinoma (iCCA) can originate from the large bile duct group (segment bile ducts and area bile ducts), ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...